CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company
Edesa Biotech, Inc.
Sign in to watch- Ticker
- EDSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (905) 475-1234
- Business address
- C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
- Former names
- Stellar Biotechnologies, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-05 | Sistilli Carlo Director | Option exercise · Common Share Warrants (Right to Buy) | −1,218 | 0 | ||
| 2020-11-05 | Nijhawan Pardeep Chief Executive Officer | Option exercise | +4,628 | $4.00 | $19K | 2,128,652 |
| 2020-11-05 | Nijhawan Pardeep Chief Executive Officer | Option exercise · Common share warrants (Right to buy) | −4,628 | 0 | ||
| 2020-11-02 | van der Velden Peter Director | Option exercise | +64,362 | $4.00 | $257K | 1,897,428 |
| 2020-11-02 | van der Velden Peter Director | Option exercise | +5,952 | $4.00 | $24K | 175,454 |
| 2020-11-02 | van der Velden Peter Director | Option exercise · Common Share Warrants (Right to Buy) | −64,362 | 0 | ||
| 2020-11-02 | van der Velden Peter Director | Option exercise · Common Share Warrants (Right to Buy) | −5,952 | 0 | ||
| 2020-10-13 | Sistilli Carlo Director | Grant or award · Stock option (right to buy) | +20,000 | 20,000 | ||
| 2020-10-13 | Brooks Michael J President | Grant or award · Stock option (right to buy) | +50,000 | 50,000 | ||
| 2020-10-13 | OAKES FRANK R. Director | Grant or award · Stock option (right to buy) | +20,000 | 20,000 | ||
| 2020-10-13 | Pay Paul William Director | Grant or award · Stock option (right to buy) | +20,000 | 20,000 | ||
| 2020-10-13 | Nijhawan Pardeep Chief Executive Officer | Grant or award · Stock option (right to buy) | +60,000 | 60,000 | ||
| 2020-10-13 | van der Velden Peter Director | Grant or award · Stock option (right to buy) | +20,000 | 20,000 | ||
| 2020-10-13 | MacDonald Sean Arthur Director | Grant or award · Stock option (right to buy) | +20,000 | 20,000 | ||
| 2020-10-13 | NIFFENEGGER KATHI Chief Financial Officer | Grant or award · Stock option (right to buy) | +50,000 | 50,000 | ||
| 2020-10-13 | JOHNSON LORIN K Director | Grant or award · Stock option (right to buy) | +20,000 | 20,000 | ||
| 2020-10-06 | OAKES FRANK R. Director | Option exercise | +609 | $4.00 | $2K | 1,827 |
| 2020-10-06 | OAKES FRANK R. Director | Option exercise · Common Share Warrants (Right to Buy) | −609 | 0 | ||
| 2020-09-17 | Nijhawan Pardeep Chief Executive Officer | Other acquisition | +371,727 | 371,727 | ||
| 2020-05-27 | Brooks Michael J President | Purchase | +1,500 | $3.00 | $4K | 3,327 |
Page 9 of 15 · 284 trades